Membership
NLA Education and Training
Lipid Scholarship Program
LipidSpin
JCL
Find a Member

Features


December 20, 2024

Ionis Receives FDA Approval for TRYNGOLZA (Olezarsen) for Adults with FCS

On December 19, 2024, Ionis Pharmaceuticals, Inc. received FDA approval for TRYNGOLZA (Olezarsen) as an adjunct to...

Read More...

November 22, 2024

Call for NLA Board Nominations is Open!

Call for Nominations is open for the National Lipid Association Board of Directors and Chapter officers and will...

Read More...

July 11, 2024

From a to B, then Back to LDL: Transatlantic Views on the Lipoproteins that Cause Plaque

The National Lipid Associations outstanding joint session with the European Atherosclerosis Society originally...

Read More...

May 31, 2024

NLA Unveils New Mission to Advance Lipidology and Cardiometabolic Health

JACKSONVILLE, Fla. – (May 31, 2024) - The National Lipid Association (NLA) is proud to announce its renewed mission: “...

Read More...

May 29, 2024

Arrowhead Pharmaceutials Announces the Publication of Two Back-to-back NEJM Manuscripts

Arrowhead Pharmaceuticals is proud to announce the publication of two back-to-back NEJM manuscripts in the mixed...

Read More...